SOURCE: BioHorizons, Inc.

BioHorizons, Inc.

June 24, 2010 08:00 ET

BioHorizons, Inc. Files Registration Statement for Initial Public Offering of Common Stock

BIRMINGHAM, AL--(Marketwire - June 24, 2010) -  BioHorizons, Inc. today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock.

Piper Jaffray & Co. and Jefferies & Company, Inc. will act as joint book-running managers of the offering. Canaccord Genuity and Cowen and Company will act as co-managers for the offering. The offering will be made only by means of a prospectus.

Copies of the preliminary prospectus, when available, may be obtained by contacting Piper Jaffray & Co., Prospectus Department, 800 Nicollet Mall, Suite 800, Minneapolis, MN, 55402 (telephone: 800-747-3924/email: prospectus@pjc.com) or Jefferies & Company, Inc., Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022 (telephone: 877-547-6340/email: Prospectus_Department@Jefferies.com)

About BioHorizons, Inc.
BioHorizons, Inc. is a medical technology company focused on developing, manufacturing and marketing a broad and comprehensive line of innovative, proprietary and evidence-based dental implants, as well as hard and soft tissue regeneration products, for the replacement of missing teeth.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

Contact Information

  • For more information:

    David A. Wall
    Chief Financial Officer
    BioHorizons, Inc.
    (205) 967-7880
    Email Contact

    Lynn C. Pieper
    Westwicke Partners
    (415) 202-5678
    Email Contact